Honing the Double-Edged Sword: Improving Human iPSC-Microglia Models

Anne Hedegaard1, Szymon Stodolak1, William S James1

  • 1Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.

Frontiers in Immunology
|December 28, 2020
PubMed

Insights

Human induced pluripotent stem cell (hiPSC)-derived microglia offer insights into neuroinflammation. Current models face challenges in balancing physiological relevance, reproducibility, and scalability for neurodegenerative disease research.

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Immunology

Background:

  • Neuroinflammation is a critical factor in neurodegenerative diseases and aging.
  • Microglia are key immune cells involved in neuroinflammation.
  • Human induced pluripotent stem cell (hiPSC)-derived microglia are emerging as a powerful research tool.

Purpose of the Study:

  • To evaluate current hiPSC-derived microglial models for studying neuroinflammation.
  • To identify limitations in existing models regarding physiological relevance, reproducibility, and scalability.
  • To pinpoint areas for improvement in the *in vitro* microglial environment.

Main Methods:

  • Analysis of key features in the *in vitro* microglial environment.
  • Examination of media composition, extracellular matrix, and co-culture systems.
  • Review of existing hiPSC-microglia model methodologies.

Main Results:

  • A variety of hiPSC-microglia models exist, from monocultures to xenotransplantation.
  • Achieving a balance of physiological relevance, reproducibility, and scalability remains a significant challenge.
  • Specific *in vitro* environmental factors require optimization for enhanced model utility.

Conclusions:

  • Optimizing media composition, extracellular matrix, and co-culture strategies is crucial for advancing hiPSC-microglia models.
  • Improved *in vitro* models will enhance the study of neuroinflammation in neurodegenerative diseases.
  • Further development is needed to create more robust and translatable hiPSC-microglia systems.